Ye, S., Fox, M. I., Belmar, N. A., Sho, M., Chao, D. T., Choi, D., . . . Culp, P. A. Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells. Wiley.
Chicago Style (17th ed.) CitationYe, Shiming, et al. Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity Through Attracting and Activating Innate Immune Effector Cells. Wiley.
MLA (9th ed.) CitationYe, Shiming, et al. Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity Through Attracting and Activating Innate Immune Effector Cells. Wiley.
Warning: These citations may not always be 100% accurate.